This Is An Image Of The Structural Formula Of Allopurinol. (Allopurinol 1)
Allopurinol Tablet
Product Images NDC 0603-2115
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 0603-2115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
This An Image Demonstrating That Allopurinol Is A Structural Analogue Of The Natural Purine Base Of Hypoxanthine. (Allopurinol 2)
Allopurinol and oxipurinol are chemical compounds that affect the production of uric acid in the human body. Hypoxanthine, xanthine, and uric acid are related purine compounds that are part of the metabolic pathway that produces uric acid. These compounds have complex chemical structures, including pyrazole and pyrimidine rings, and are involved in a number of biochemical processes.*
An Image Of The Allopurinol Tablets, Usp 100 mg 100 Tablets Label. (Allopurinol 3)
This is the prescribing information for Allopurinol tablets USP, with each tablet containing 100 mg of Allopurinol. The tablets should be dispensed in a light-resistant container and stored at room temperature, between 20-25°C (68-77°F). The drug is only available via prescription and follows the guidelines set by the US Pharmacopeia (USP). The GTIN is provided as 00306032115218, and the medication is distributed by an unknown entity.*
An Image Of The Allopurinol Tablets, Usp 300 mg 100 Tablets Label. (Allopurinol 4)
This is a description of Allopurinol, a USP drug that can help reduce the production of uric acid in the human body when taken properly. The medication comes in a pack containing 100 tablets, each tablet containing 100mg of Allopurinol, which is the recommended dosage. The usual medication instructions are included in the package insert, which should be consulted carefully before using the drug. The medication should be kept out of reach of children and stored in a tight, light-resistant container within the USP-controlled room temperature range of 20°C to 25°C (68°F to 77°F). The medicine is distributed by Par Pharmaceutical, Chestnut Ridge, NY, and manufactured by Par Formulations Private Limited in Kelambakkam, India. Finally, the document features some additional regulatory information, including a manufacturer's license number and a product code.*
Allopurinol 5
NDC 0603-2116-21 is a prescription drug containing Allopurinol in the form of tablets with a strength of 300mg. It is dispensed in a light-resistant container as defined by the USP and should be stored at a temperature range of 20° to 25°C. The drug is distributed by Par Pharmaceutical and each container has 100 tablets. The GTIN number for this product is 00306032116215.*
Allopurinol 6
This is a description of Allopurinol Tablets, USP, with NDC number 0603-2116-21, containing 100 tablets of 300mg Allopurinol, USP. It is for Rx only and usual dosage should be followed according to package insert for full prescribing information. It should be kept out of reach of children and stored in a tight, light-resistant container as defined in the USP, at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperaturel. The drug is distributed by Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A., and made in India by Par Formulations Private Limited, 9/215, Pudupakkam, Kelambakkam - 603 103. The Mifg Lic. No. is TNO0002121. The unvarnished area of the description is W 20 x H 45 mm.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
